undamentalytics Newsletter
Sign in

Co-diagnostics, Inc. revenue

Co-diagnostics, Inc.'s revenue was $622,489 in fiscal 2025, down 84.1% on the year before. Since fiscal 2017 ($7,662) it has grown at a compound 73.3% a year. Over the last twelve months it was $721,387.

Revenue history

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue0007598347411
Growth on the year before—+420.9%+438.6%+>999%+31.3%−65.0%−80.1%−42.5%−84.1%—
Gross profit0005886293300
Gross margin96.1%76.5%47.7%77.7%88.2%84.0%38.6%74.5%64.3%43.5%

Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.

Where the revenue comes from

Fiscal year to December 31, 2025
Products and services
Line of business Revenue Share YoY
Products $418,205 67.2% ▼ 45.7%
Grant $204,284 32.8% ▼ 93.5%
Geography
Region Revenue Share YoY
United States $581,549 93.4% ▼ 83.5%
Outside the US $40,940 6.6% ▼ 89.6%

From Co-diagnostics, Inc.'s 10-K filed March 31, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.

Revenue against peers

Health Care Equipment: the closest covered companies by revenue. Last twelve months.

CompanyRevenueGrowth3-year growth a year
Co-diagnostics, Inc. $721,387 -28.1% -53.8%
Itonic Holdings Ltd $523,031 16.7% —
Pulse Biosciences, Inc. $1.2m 100.0% —
Insight Molecular Diagnostics Inc. $1.7m -60.8% 14.9%
Seastar Medical Holding Corp $1.7m 123.6% —
Qtrex Quantum Ltd. $289,000 — —

Compare with peers

Head to head: CODX vs ITOCCODX vs PLSECODX vs IMDXCODX vs QTEX

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Co-diagnostics, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Co-diagnostics, Inc.